Work

Cost identification of an individualized dosing strategy for lutenizing hormone releasing hormone agonist (LH-RHa) in the treatment of hormone refractory prostate cancer (HRPC)

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.4588

Authors: J. A. Wagmiller, A. W. Dick, D. M. Sahasrabudhe

Institution: University of Rochester

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2604909381

Cites:

Cited by:

Related to: 10